Xiaoli Fu

Enhancing the biocatalytic synthesis of chiral drug intermediate by rational design an aldo-keto reductase from Bacillus megaterium YC4-R4.

Rui Pei, Shun-Feng Zhou, Wei Jiang, 2022, Enzyme and microbial technology.

Predictive Values of Anthropometric Measurements for Cardiometabolic Risk Factors and Cardiovascular Diseases Among 44 048 Chinese

Yang Wang, Wenhua Zhao, S. Rangarajan, 2019, Journal of the American Heart Association.

3D-Printed Aldo-keto reductase within biocompatible polymers as catalyst for chiral drug intermediate

Rui Pei, Shu-Feng Zhou, Wei Jiang, 2022, Chemical Engineering Journal.

Programmable and printable formaldehyde dehydrogenase as an excellent catalyst for biodegradation of formaldehyde

Guangya Zhang, Wei Jiang, Rui Pei, 2023, International journal of bioprinting.

Docking to Search for Potential Competitive Inhibitors of Chitin

Yujun, G. Wang, H. Yao, 2020 .

Specific coenzyme preference switching for an aldo-keto reductase that synthesizes the chiral intermediate of duloxetine.

Wei Jiang, Xiaoli Fu, Lingzhi Zhang, 2023, Enzyme and Microbial Technology.